皮罗尼病急性期:我们站在哪里?
Konstantinos Douroumis1, Konstantinos Kotrotsios1, Panagiotis Katsikatsos1
1Department of Urology, National and Kapodistrian University of Athens, Athens, GRC.
Cureus
|September 17, 2024
概括
皮罗尼氏病 (PD) 管理侧重于急性阶段的保守治疗,避免手术. 目前的最佳策略结合了PDE5抑制剂,ESWT,PTT和内伤注射等疗法.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 安德罗学与人类学
- 再生医学是一种再生医学.
背景情况:
- 皮罗尼氏病 (PD) 涉及阴茎纤维化和曲.
- 微创伤和炎症是关键的病原遗传因素.
- 病发症呈现在急性和慢性阶段,具有急性阶段特征的疼痛.
研究的目的:
- 审查急性期皮罗尼病的保守治疗选择.
- 为了确定急性PD的当前最佳治疗策略.
- 突出需要进一步研究急性PD管理的需要.
主要方法:
- 对急性皮罗尼病的保守治疗方法的审查.
- 讨论口服,局部,内伤疗法,ESWT和PTT.
- 对联合治疗方法的现有证据的综合.
主要成果:
- 建议对急性期PD进行保守治疗,以避免手术风险.
- 包括PDE5抑制剂,ESWT,PTT和内伤疗法在内的综合策略目前被认为是最佳的.
- 疼痛管理是急性阶段的主要目标.
结论:
- 对于急性皮罗尼病的最佳管理,需要采用多模式的保守方法.
- 进一步的大规模随机对照试验至关重要,以确认各种治疗方案的疗效.
- 在急性阶段避免手术对于更好的长期结果至关重要.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
136
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
136
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
160
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
160
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
147
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
147
Peptic Ulcer Disease V: Surgical Management and Nursing Care
246
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
246
Vascular Spasm
1.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.3K


